Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
BOSTON, Feb 11, 2026 – (ACN Newswire) – Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed […]
BOSTON, Feb 11, 2026 – (ACN Newswire) – Bioxytran, Inc. (OTCQB: BIXT) today announced positive clinical results from its recently completed […]